[HTML][HTML] Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeutics
BA Babalola, OS Akinsuyi, EO Folajimi, F Olujimi… - Biomedicine & …, 2023 - Elsevier
One of the most pressing challenges associated with SARS-CoV-2 treatment is the
emergence of new variants that may be more transmissible, cause more severe disease, or …
emergence of new variants that may be more transmissible, cause more severe disease, or …
Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeutics
BA Babalola, OS Akinsuyi, EO Folajimi… - Biomedicine & … - pubmed.ncbi.nlm.nih.gov
One of the most pressing challenges associated with SARS-CoV-2 treatment is the
emergence of new variants that may be more transmissible, cause more severe disease, or …
emergence of new variants that may be more transmissible, cause more severe disease, or …
Exploring the Future of Sars-cov-2 Treatment After the First Two Years of the Pandemic: a Comparative Study of Alternative Therapeutics
BA Babalola, OS Akinsuyi, EO Folajimi, F Olujimi… - 2023 - docs.lib.purdue.edu
One of the most pressing challenges associated with SARS-CoV-2 treatment is the
emergence of new variants that may be more transmissible, cause more severe disease, or …
emergence of new variants that may be more transmissible, cause more severe disease, or …
Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeutics.
BA Babalola, OS Akinsuyi, EO Folajimi… - Biomedicine & …, 2023 - europepmc.org
One of the most pressing challenges associated with SARS-CoV-2 treatment is the
emergence of new variants that may be more transmissible, cause more severe disease, or …
emergence of new variants that may be more transmissible, cause more severe disease, or …